While it is known sales of the entire sector declined in FY14, the balance sheets of these companies have shown a marked improvement, as net working capital fell for nine of the 12 companies and net debt declined for seven.
Most companies saw a decline in capital expenditure, while free cash generation largely remained stable for the sector.
However, return on equity (RoE) declined for seven companies, which partly explains the disenchantment of investors with the sector.
For HUL, Marico, Britannia and Emami, the RoE increased; these are companies that have fared better than the rest in this sector.
This possibly explains the high valuation multiple HUL continues to command, despite weak sales.
IIFL's note says: "The highest RoE in the sector is HUL's, at 113.6 per cent, due to low fixed capital intensity and negative working capital."
HUL's RoE jumped due to lower cash balances after it paid a special dividend in FY13.
By contrast, at 12.5 per cent, Jyothy Labs had the lowest RoE in the sector, owing to higher working capital and capital base.
Colgate saw its RoE decline sharply in FY14 on a lower dividend payout and a rise in net worth.
On the bright side, gross margins expanded for the sector in FY14 on lower input prices.
Leading the sector on this front was ITC, with gross margins at 63.1 per cent of sales.
Close on its heels were GSK Consumer and Emami.
Photograph: Amit Dave/Reuters
Brands enhance marketing budgets to push online sales
Why investors are shying away from FMCG stocks
How India became a high-priority market for PepsiCo
SPECIAL: The man who changed the game at Marico
Sensex snaps nine-day winning streak to end below 27,100